DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tardive dyskinesia
Tardive dyskinesia
Tardive Dyskinesia
Tourette's Syndrome
Tourette-Like Syndrome Following Low Dose Short-Term Neuroleptic Treatment Samarthji Lai and Esam Alansari
Clinical Study Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X Syndrome
Current P SYCHIATRY
Tardive Dyskinesia
Fragile X Syndrome
Medical Intervention in Fragile X Syndrome
Movement Disorders Therapeutic Class Review (TCR)
Persistent Akathisia Associated with Early Tardive Dyskinesia THOMAS R
Tardive Akathisia
What Is Tardive Dyskinesia?
Tardive Dyskinesia Tip Sheet
Tardive Dyskinesia
Tardive Dyskinesia (TD)
Letters to the Editor
Clinical Course and Cellular Pathology of Tardive Dyskinesia
Drug Induced Parkinsonism and Tardive Dyskinesia Are Iatrogenic Consequences of the Use of Antidopaminergic Drugs
Top View
Tardive Dyskinesia: Minimizing Risk and Improving Outcomes in Schizophrenia and Other Disorders
Drug-Induced EPS, Akathisia, and Tardive Dyskinesia Learning Objectives
Quetiapine-Associated Tardive Dyskinesia
Recent Advances in the Pharmacology of Tardive Dyskinesia
Tardive Dyskinesia
Methods of Treating Fragile X Syndrome
Neuropsychiatry of Movement Disorders Kevin J
Expected Incidence of Tardive Dyskinesia Associated with Atypical Antipsychotics
Aging in Fragile X Syndrome
Obsessive Compulsive Disorders: an Information Guide
Late-Onset Quetiapine-Related Tardive Dyskinesia Side Effects in a Patient with Psychotic Depression
For Behavior in Fragile X Syndrome
Deuterium Tetrabenazine for Tardive Dyskinesia Michael A
Tardive and Idiopathic Oromandibular Dystonia: a Clinical Comparison
Clinical Use of Quetiapine in Disease States Other Than Schizophrenia
How AUSTEDO® Treats Uncontrolled Movements of Tardive Dyskinesia
Amphetamine-Induced Dopamine Release and Post-Synaptic Specific Binding in Patients with Mild Tardive Dyskinesia Caleb M
Medications for Individuals with Fragile X Syndrome
Schizophrenia Is a Pervasive, Chronic
Striatal Dopamine D2 Receptors in Tardive Dyskinesia: PET Study
Resistant Somatoform Symptoms: Try CBT and Antidepressants Preferred Strategy for ‘Mismatched’ Category of Illnesses
D2-Receptor Upregulation Is Dependent Upon Temporal 11 Course of D2-Occupancy: a Longitudinal [ C]-Raclopride PET Study in Cats
Tardive Dyskinesia and Dopamine Oxidation, Cumulative Effects
Tardive Dyskinesia Awareness
Therapeutic Perspective on Tardive Syndrome with Special Reference to Deep Brain Stimulation
AUSTEDO (Deutetrabenazine) Tablets, for Oral Use Metabolizers Is 36 Mg Per Day (I.E., 18 Mg Twice Daily) (2.4, 8.7) Initial U.S
Topographic Subtypes of Tardive Dyskinesia in Schizophrenic
Tardive Dyskinesia Following Risperidone Treatment in Tourette
Association Study of Tardive Dyskinesia and Five DRD4 Polymorphisms in Schizophrenia Patients
Tardive Dyskinesia
Seroquel Tablets
Drug-Induced Movement Disorders